ArticleFrontiers in oncology2025

Unveiling the traits of HER2-low breast cancer: a comparative analysis of IHC1+ vs IHC2+/ISH-negative subgroups - insights from a 3-year cohort study.

Jorge Correia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.